Turkiye Klinikleri Journal of Pediatrics

.: ORIGINAL RESEARCH
Correlation Between Patient's Adherence and Glycemic Control in Children with Type 1 Diabetes During the COVID-19 Pandemic: A Cross-Sectional Study
Tip 1 Diyabetli Çocuklarda COVID-19 Pandemisi Sürecinde Hasta Uyumu ve Glisemik Kontrol Arasındaki Korelasyon: Kesitsel Bir Çalışma
Nur ROCHMAHa,b, Muhammad FAIZIa,b, Yuni HISBIYAHa,b, Jeny ROSANINGRUMd, Bambang Subakti ZULKARNAINd, Anang ENDARYANTOa,b, Soetjipto SOETJIPTOa,c
aPost Graduate Study, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA
bFaculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Surabaya, INDONESIA
cDepartment of Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA
dDepartment of Clinical Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya, INDONESIA
Turkiye Klinikleri J Pediatr. 2022;31(1):39-44
doi: 10.5336/pediatr.2021-83526
Article Language: EN
Full Text
ABSTRACT
Objective: The pandemic condition has hampered the health system because of government efforts to limit the spread of the coronavirus disease-2019 (COVID-19). These restrictions can affect the management of children with Type 1 diabetes mellitus (T1DM). We aimed to assess the correlation between patient adherence and glycemic control during early pandemic. Material and Methods: T1DM patients who regularly control to Pediatric Endocrine Outpatient Clinic of Dr. Soetomo Hospital, aged 4-18 years old and whose parents were willing to jjoin this study were included. The sample was randomly collected by phone from July 2nd to 28th, 2020 (during early pandemic). We used the Diabetes Management Questionnaire (DMQ) (parents-reported method for children aged 13 years). The correlation between variables was analyzed by using Pearson correlation test. Results: Thirty patients were included in our study (mean age: 11.70±3.49 years old; the mean DMQ score: 56.33±11.30). The mean (±SD) HbA1c level was 11.35 (1.95) %. The DMQ score consists of 4 sectors, including adherence to insulin use, diet management, physical activity and glycemic monitoring, the means of patient's score vs maximum score as followed (10.00 vs 10.00), (24.83 vs 40.00), (6.87 vs 15), (18.25 vs 35). Unfortunately, the correlation analysis on patient's adherence and HbA1c was not significant (r=-0.231; p=0.164). Conclusion: The correlation between patient's adherence and HbA1c was not significant. Meanwhile, adherence to insulin showed maximal score during early COVID-19 pandemic.

Keywords: T1DM; COVID-19; children; adherence; glycemic control
ÖZET
Amaç: Pandemik koşullar hükümetin koronavirüs hastalığı2019 (COVID-19)'un yayılımını sınırlamak için girdiği çabalar nedeniyle sağlık sistemini aksatmıştır. Bu kısıtlamalar Tip 1 diabetes mellituslu (T1DM) çocukların yönetimini etkileyebilir. Erken COVID- 19 pandemisi sürecinde hasta uyumu ile glisemik kontrol, glikolize hemoglobin (HbA1c) arasındaki korelasyonu değerlendirmeyi amaçladık. Gereç ve Yöntemler: Yaşları 4 ile 18 arasında değişen, Dr. Soetomo Hastanesi Pediyatrik Endokrin Polkliniğine düzenli olarak kontrole gelen ve ebeveynleri çalışmaya katılmaya istekli olan T1DM tanılı çocuklar çalışmaya alındı. Verileri 2-28 Temmuz 2020 tarihleri arasında (erken pandemi dönemi) telefon görüşmesi yoluyla rastgele örneklem yöntemi ile çevrimiçi olarak topladık. Diyabet Yönetimi Anketini (DYA) (13 yaş çocukların kendilerinin doldurduğu bir anket) kullandık. Değişkenler arasındaki korelasyon Pearson korelasyon testi kullanılarak incelendi. Bulgular: Çalışmamıza 30 hasta alındı (ortalama yaş 11,70±3,49 yıl; ortalama DYA skoru 56,33±11,30). DYA insülin kullanımına uyum, diyet yönetimi, fiziksel aktivite ve glisemik takip olmak üzere 4 bölümden oluşmaktadır. Hasta skorlarının ortalaması vs DYA anketinin her bölümünün maksimum skoru şöyleydi: 10,00 vs 10,00), (24,83 vs 40,00), (6,87 vs 15), (18,25 vs 35). Her DYA bölümünün HbA1c ile korelasyonu şöyleydi: sırasıyla (r=0,026; p=0,893), (r=-0,058; p=0,761), (r=-0,004; p=0,982), (r=0,007; p=0,973). Ortalama (±SS) HbA1c düzeyi 11,35 (1,95) % idi. Maalesef, hasta uyumu ile HbA1cnin korelasyon analizi anlamlı değildi (r=0,231; p=0,164). Sonuç: Çalışmamızda hasta uyumu ile HbA1c arasındaki korelasyon anlamlı değildi. Bu arada, insüline uyum erken COVID-19 pandemisi döneminde maksimum skoru aldı.

Anahtar Kelimeler: T1DM; COVID-19; çocuklar; uyum; glisemik kontrol
REFERENCES:
  1. Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365-88. [Crossref]  [PubMed] 
  2. Nugraha B, Wahyuni LK, Laswati H, Kusumastuti P, Tulaar AB, Gutenbrunner C. COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia. Acta Med Indones. 2020;52(3):299-305. [PubMed] 
  3. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020;127:104354. [Crossref]  [PubMed]  [PMC] 
  4. O'Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, et al. COVID-19 hospitalization in adults with type 1 diabetes: results from the T1D exchange multicenter surveillance study. J Clin Endocrinol Metab. 2021;106(2):e936-42. [Crossref]  [PubMed]  [PMC] 
  5. d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, et al. Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract. 2020;168:108372. [Crossref]  [PubMed]  [PMC] 
  6. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95-104. [Crossref]  [PubMed]  [PMC] 
  7. Delameter AM. Improving patient adherence. Clinical Diabetes. 2006;24(2):71-7. [Crossref] 
  8. Chowdhury S, Goswami S. COVID-19 and type 1 diabetes: dealing with the difficult duo. Int J Diabetes Dev Ctries. 2020:1-6. [Crossref]  [PubMed]  [PMC] 
  9. Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021;44(2):526-32. [Crossref]  [PubMed]  [PMC] 
  10. Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab Syndr. 2020;14(5):1213-6. [Crossref]  [PubMed]  [PMC] 
  11. Mehta SN, Nansel TR, Volkening LK, Butler DA, Haynie DL, Laffel LM. Validation of a contemporary adherence measure for children with Type 1 diabetes: the Diabetes Management Questionnaire. Diabet Med. 2015;32(9): 1232-8. [Crossref]  [PubMed]  [PMC] 
  12. Rochmah N, Faizi M, Hisbiyah Y, Triastuti IW, Wicaksono G, Endaryanto A, et al. Quality of life differences in pre- and post-educational treatment in type 1 diabetes mellitus during COVID-19. Diabetes Metab Syndr Obes. 2021;14:2905-11. [Crossref]  [PubMed]  [PMC] 
  13. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-24. [Crossref]  [PubMed] 
  14. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171-9. [Crossref]  [PubMed] 
  15. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004; 38(9):1357-62. [Crossref]  [PubMed] 
  16. Lai Ying C, Shah NM. Adherence to insulin treatment in children with type i diabetes mellitus at a hospital in Malaysia. Asian Journal of Pharmaceutical and Clinical Research. 2017;10(11):356-61. [Crossref] 
  17. Seckold R, Howley P, King BR, Bell K, Smith A, Smart CE. Dietary intake and eating patterns of young children with type 1 diabetes achieving glycemic targets. BMJ Open Diabetes Res Care. 2019;7(1):e000663. [Crossref]  [PubMed]  [PMC] 
  18. MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014; 15(3):175-89. [Crossref]  [PubMed] 
  19. Gökşen D, Atik Altınok Y, Ozen S, Demir G, Darcan S. Effects of carbohydrate counting method on metabolic control in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2014;6(2):74-8. [Crossref]  [PubMed]  [PMC] 
  20. Döğer E, Bozbulut R, Soysal Acar AŞ, Ercan Ş, Kılınç Uğurlu A, Akbaş ED, et al. Effect of telehealth system on glycemic control in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol. 2019;11(1):70-5. [Crossref]  [PubMed]  [PMC] 
  21. Tao J, Gao L, Liu Q, Dong K, Huang J, Peng X, et al. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic. Diabetes Res Clin Pract. 2020;170:108514. [Crossref]  [PubMed]  [PMC] 
  22. Pulungan AB, Fadiana G, Annisa D. Type 1 diabetes mellitus in children. Clin Pediatr Endocrinol. 2021;30(1):11-8. [Crossref]  [PubMed]  [PMC] 
  23. Beraki Å, Magnuson A, Särnblad S, Åman J, Samuelsson U. Increase in physical activity is associated with lower HbA1c levels in children and adolescents with type 1 diabetes: results from a cross-sectional study based on the Swedish pediatric diabetes quality registry (SWEDIABKIDS). Diabetes Res Clin Pract. 2014;105(1):119-25. [Crossref]  [PubMed] 
  24. Carral F, Gutiérrez JV, Ayala Mdel C, García G, Aguilar M. Intense physical activity is associated with better metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2013;101(1):45-9. [Crossref]  [PubMed] 
  25. Gandhi K, Vu BK, Eshtehardi SS, Wasserman RM, Hillliard ME. Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice. Diabetes Manag (Lond). 2015;5(6):485-98. [Crossref]  [PubMed]  [PMC] 
  26. Gomes KF, Semzezem C, Batista R, Fukui RT, Santos AS, Correia MR, et al. Importance of zinc transporter 8 autoantibody in the diagnosis of type 1 diabetes in Latin Americans. Sci Rep. 2017;7(1):207. [Crossref]  [PubMed]  [PMC] 
  27. Bhatty A, Baig S, Fawwad A, Rubab ZE, Shahid MA, Waris N. Association of zinc transporter-8 autoantibody (ZnT8A) with type 1 diabetes mellitus. Cureus. 2020;12(3):e7263. [Crossref]  [PubMed]  [PMC] 
  28. Braga de Souza AC, Felício JS, Koury CC, Neto JF, Miléo KB, Santos FM, et al; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG). Health-related quality of life in people with type 1 diabetes mellitus: data from the Brazilian Type 1 Diabetes Study Group. Health Qual Life Outcomes. 2015;13:204. [Crossref]  [PubMed]  [PMC] 
  29. Park YJ, Yoo SA, Kim WU. Role of endoplasmic reticulum stress in rheumatoid arthritis pathogenesis. J Korean Med Sci. 2014;29(1): 2-11. [Crossref]  [PubMed]  [PMC] 
  30. Kiani AK, John P, Bhatti A, Zia A, Shahid G, Akhtar P, et al. Association of 32 type 1 diabetes risk loci in Pakistani patients. Diabetes Res Clin Pract. 2015;108(1):137-42. [Crossref]  [PubMed] 
  31. Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009;52(9):1881-8. [Crossref]  [PubMed] 
  32. Mattana TC, Santos AS, Fukui RT, Mainardi-Novo DT, Costa VS, Santos RF, et al. CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort. Mediators Inflamm. 2014;2014:694948. [Crossref]  [PubMed]  [PMC] 

.: Up To Date



Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com